Diligence memo · auto-generated · as of July 2, 2026
Cx Precision Medicine, Inc.
Cx Precision Medicine, Inc. looks fair against its niche peers and is quiet on financing cadence.
Businessfiled
Cx Precision Medicine, Inc. operates in Other Health Care, based in FORTH WORTH.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
Cx Precision Medicine, Inc. has raised $7.0M in disclosed capital across 5 recorded rounds, aggregated from public filings. Its latest round is modeled as Seed (a $1.0M–$4.0M round).
Largest single filing: $4.0M on 2024-06-26.
Most recent recorded round closed around 2024-06-26.
Valuation (modeled)modeled
Provath models Cx Precision Medicine, Inc. at approximately $18M (range $3.4M–$48M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Read: Fair. Modeled value is 1.49× the median modeled value of Seed Other Health Care companies in 2022–2024 (244 peers) — value vs value, same stage and era. Within the normal band (149% of peer median) for its niche.
Financing rhythm & timingmixed
Historic cadence: a new round about every 24 months.
Last raise 2.0 yr ago; this sector typically re-raises about every 14 months.
Slightly overdue versus sector cadence.
The last round stepped up 3.3× from the prior — scaling.
Comparablesmixed
Capital scale ranks ahead of 70% of Other Health Care peers (5377 compared).
Modeled value ranks above 46% of those peers.
Closest niche peers: Elmntri LLC, Atreo, Inc., descendantsDNA, Inc., Westover Project Investor LLC, Dentulu Inc.
Peoplefiled
8 named people on file across officers, directors and signatories.
Risks & flagsmixed
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.